Disorders of Sphingolipid Metabolism
1 clinical trials · Condition
◉ Watch Disorders of Sphingolipid Metabolism
| Record | Firm | Date |
|---|---|---|
| Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects (NCT05238714) | Genzyme, a Sanofi Company | 2020-05-26 |
Track Disorders of Sphingolipid Metabolism automatically
Every clearance here is in the API, with alerts when new ones post.